Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
      1
23
4
5678
910111213
14
15
16
17
1819202122
23242526272829
30      
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More
| 1 |

 
 
  Tags
 
Opioid Treatment health reform painkillers cocaine treatment alcohol dependence flumazenil vicodin Health Care Utilization opiod abuse substance use disorder randomized naloxone oxycodone chronic pain contract stress fentanyl drug use addiction recovery Opioid Medications Journal of Psychopharmacology substance dependence costs prometa ADHD drinking behavioral healthcare percocet anxiety buprenorphine relapse smoking drug abuse craving opioid antagonist alcohol drinking social network Research Across America morphine addict methamphetamine depression hospitalizations meth mental health treatment medical and behavioral costs Harold Urschel muscle relaxant withdrawal PTSD stratified ADD opiod-based double-blind post-traumatic stress disorder OxyContin gabapentin urine drug screen communication pain medication pain pills physician- patient relations marijuana nicotine medical diabetes depression screening reducing craving health plan hospital alcohol treatment pain killers vivitrol reduction in use placebo-controlled identification drug addicts reduction in craving opioid overdose behavioral healthcare services alcoholism stimulants overdose craving score SD health insurance care coaching over-the-counter substances SD members emergency room recovery network substance dependence health insurance binge drinking Catasys predictive modeling CIWA methadone drug addiction primary care alcohol behavioral health Raymond Anton cigarettes behavioral health care services opioid-drug interactions data mining placebo drug treatment relapse prevention Opioid Prescribing ER trauma behavioral health care heroin hydrocodone UnitedHealthcare methamphetamine dependence bipolar disorder medical costs sobriety prescriptions high-utilizing cocaine suboxone opioid abuse drug overdose OnTrak dependence issues opioid addiction treatment sugar substance dependence health insurance opiates facebook mental illness codeine narcotic sober Co Occurring Disorders psychosocial
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414